BrianBBergerMDboard certified
Ophthalmology • Austin, TXRetinal Disease, Uveitis
president, Retina Research Center
Dr. Berger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9707 Anderson Mill Rd Ste 100
Austin, TX 78750Phone+1 512-279-1251Fax+1 512-454-5853
Education & Training
Medical College of Wisconsin Affiliated HospitalsResidency, Ophthalmology, 1979 - 1980
University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 1976 - 1979
Valleywise HealthInternship, Transitional Year, 1975 - 1976
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1975
Certifications & Licensure
TX State Medical License 1981 - 2026
IL State Medical License 1976 - 2014
WI State Medical License 1979 - 1981- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Top Doctors:SE Texas Castle Connolly, 2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) Start of enrollment: 2010 Jun 01
- Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Start of enrollment: 2011 Oct 01
- A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study) Start of enrollment: 2012 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsPhase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema.Pravin U Dugel, Arshad M Khanani, Brian B Berger, Sunil Patel, Mitchell Fineman
Translational Vision Science & Technology. 2021-12-01 - 119 citationsReproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema.Magdalena G. Krzystolik, Strauber Sf, Lloyd Paul Aiello, Roy W. Beck, Brian B. Berger
Ophthalmology. 2007-03-13 - 490 citationsPanretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol, Seidu Inusah, Lloyd Paul Aiello
JAMA. 2015-11-24
Journal Articles
- A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular EdemaBrian Berger, Douglas Girgenti, Ronald A Schachar, Marla B Sultan, Investigative Ophthalmology and Visual Science
Press Mentions
Effect of Initial Management with Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients with Diabetic Macular Edema Involving the Center of the Macula and Good Visual AcuityMay 1st, 2019
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
